NEU neuren pharmaceuticals limited

Ann: Disclosure under Listing Rule 4.3D, page-59

  1. 201 Posts.
    lightbulb Created with Sketch.  29
    In the past 4 years Neuren has produced its annual report between late March and late April. So we are in the window to expect some more detail in the next few weeks.

    I am hoping they are trying to finalise the deal ahead of this or at least get some indication on what the P3 funding arrangements will likely be. Surely someone wants in!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.